GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Resmed Inc. (RMD) [hlAlert]

Rating:
Market Perform
RMD
down 6.86 %

Resmed Inc. (RMD) upgraded to Market Perform by Wells Fargo

Posted on: Friday,  Feb 5, 2010  8:25 AM ET by Wells Fargo

Wells Fargo rated Market Perform Resmed Inc. (NYSE: RMD) on 02/05/2010. Previously Wells Fargo rated Underperform Resmed Inc. (NYSE: RMD) on
01/05/2010., when the stock price was $25.63. Since then, Resmed Inc. has gained 7.38% as of 02/05/2010's recent price of $27.52.
If you would have followed the previous Wells Fargo's recommendation on RMD, you would have lost 6.86% of your investment in 31 days.

ResMed Inc. is a holding company. Through its subsidiaries, the Company develops, manufactures and distributes medical equipment for treating, diagnosing and managing sleep-disordered breathing (SDB) and other respiratory disorders, including obstructive sleep apnea (OSA). It has developed nasal continuous positive airway pressure (CPAP) as a non-invasive treatment for OSA. CPAP systems deliver pressurized air, typically through a nasal mask, to prevent collapse of the upper airway during sleep. The Company has developed a number of products for SDB and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear and other accessories. ResMed Inc. sells its products in over 70 countries through a combination of wholly owned subsidiaries and independent distributors to sleep clinics, home healthcare dealers and third-party payers. On April 30, 2009, it acquired Respicure Medsys PVT.LTD. In October 2009, ResMed Inc. acquired Laboratoires Narval.

The investment research content is provided by Wells Capital Management, a registered investment adviser and wholly owned subsidiary of Wells Fargo Bank, N.A. Our economists’ expertise on domestic markets, and national and global trends, is an important resource to the firm. Wells Capital Management economists are known for their thoughts on investment strategy, macro-economic forecasts and other top-down analysis, and share their views on bonds, midcaps and liquidity management in their publications.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/5/2010 8:25 AM Hold
None
27.52
as of 12/31/2010
1 Week   
1 Month   
3 Months   
1 YTD down  -7.37 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/5/2010 10:25 AM Sell
None
25.63

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy